GoldenGolden
Seventure Partners

Seventure Partners

Seventure Partners is a venture capital firm investing in life science and digital technology companies that was founded in 1997 and headquartered in Paris, France.

Seventure Partners is a venture capital firm that is a subsidiary of Natixis Investment Managers, and as of December 31, 2017 it has €691 million under its management. The company is headquartered in Paris, France and was founded in 1997. Seventure Partners focuses on making capital investments in life science (microbiome, nutrition, biotechnology, pharmaceuticals, medical technology, and industrial biotechnology) and digital technology (fintech, software, digital services, and digital infrastructure) companies.

Funding

Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage.

Investment funds
Sport & Performance Capital

On July 5, 2019 Seventure Partners announced launching a new fund called Sport & Performance Capital that will be focusing on supporting innovative companies and technologies in the sports and wellness industries. The fund seeks to raise a final target of €80 million to invest in European companies with an initial focus on companies operating in France.

Timeline

People

Name
Role
LinkedIn

Isabelle de Cremoux

Founder and CEO

Further reading

Title
Author
Link
Type
Date

The World's First €100M Microbiome-focused Venture Fund opened in France - Labiotech.eu

Hemme, Philip

Article

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

1000 Mercis

France

Innovative Services

A-Mansia

Belgium

Microbiome & Nutrition

Acarix

Denmark

Medtech & Diagnostics

Anaeropharma

Japan

Microbiome & Nutrition

Anevia

France

Infrastructure Technologies

Anytime

Belgium

Fintech

Aston Itrade Finance

France

Fintech

Balyo

France

Innovative Services

Biomatlante

France

Medtech & Diagnostics

BiomX

Israel

Microbiome & Nutrition

Business Table

France

Fintech

Cambrooke

USA

Microbiome & Nutrition

Chronotruck

France

Innovative Services

Corwave

France

Medtech & Diagnostics

DayTwo

Israel

Microbiome & Nutrition

Domain Therapeutics

France

Biotech & Pharmaceuticals

France

Microbiome & Nutrition

Endocontrol

France

Medtech & Diagnostics

France

Microbiome & Nutrition

Eodom

France

Innovative Services

Feetme

France

Medtech & Diagnostics

Fire1

United Kingdom

Medtech & Diagnostics

FromAtoB

Germany

Innovative Services

Global Bioenergies

France

Industrial Biotechnology

Humedics

Germany

Medtech & Diagnostics

Page 1 of 3

News

Title
Author
Date
Publisher
Description
PEP-Therapy
April 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of cancers, announces it has...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.